☆ 4.3 Article

Biphenotypic sinonasal sarcoma with PAX3::MAML3 fusion transforming into high-grade rhabdomyosarcoma: report of an emerging rare phenomenon

VIRCHOWS ARCHIV (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Oncology

RREB1::MRTFB fusion-positive extra-glossal mesenchymal neoplasms: A series of five cases expanding their anatomic distribution and highlighting significant morphological and phenotypic diversity

Abbas Agaimy et al.

Summary: This study presents five new cases of ectomesenchymal chondromyxoid tumors (EMCMT) of the tongue, including the first two extracranial/extrathoracic cases. The tumors showed diverse histological and immunohistochemical features, but all cases had the same RREB1::MRTFB fusion detected by targeted RNA sequencing. These findings expand our understanding of the topographic spectrum and heterogeneity of RREB1::MRTFB-rearranged neoplasms.

GENES CHROMOSOMES & CANCER (2023)

添加到收藏夹

Review Pathology

Biphenotypic Sinonasal Sarcoma with a Novel PAX3::FOXO6 Fusion: A Case Report and Review of the Literature

Meredith M. Nichols et al.

Summary: This study presents a case of a 54-year-old male patient with a nasal mass. Endoscopic resection revealed a low-grade spindle cell neoplasm with morphologic features consistent with BSS. Immunohistochemical and next generation sequencing were performed to confirm the diagnosis.

HEAD & NECK PATHOLOGY (2023)

添加到收藏夹

Article Pathology

Biphenotypic Sinonasal Sarcoma with PAX7 Expression

Natalia Georgantzoglou et al.

INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY (2022)

添加到收藏夹

Article Pathology

High-grade transformation of low-grade biphenotypic sinonasal sarcoma: Radiological, morphophenotypic variation and confirmatory molecular analysis

Diana Bell et al.

Summary: This article reports a case of high-grade transformation in biphenotypic sinonasal sarcoma (BSNS) and describes the clinical presentation and molecular features of this case. This transformation was not appreciated at the time of initial diagnosis and occurred 15 years after recurrence.

ANNALS OF DIAGNOSTIC PATHOLOGY (2022)

添加到收藏夹

Article Oncology

Recurrent VGLL3 fusions define a distinctive subset of spindle cell rhabdomyosarcoma with an indolent clinical course and striking predilection for the head and neck

Abbas Agaimy et al.

Summary: The VGLL3 fusion plays an important role in the tumorigenesis of a distinctive low-grade myogenic neoplasm with a predilection for the head and neck. Immunohistochemistry shows consistent expression of desmin, myogenin, and myoD1 in these tumors. Patients are usually managed surgically, with some receiving adjuvant radio- or chemotherapy. Further research is needed to fully understand the characteristics and therapeutic strategies for this tumor, which generally exhibits a benign behavior.

GENES CHROMOSOMES & CANCER (2022)

添加到收藏夹

Article Clinical Neurology

High-Grade Biphenotypic Sinonasal Sarcoma: A Case Report

Sukaina Hasnie et al.

Summary: Biphenotypic sinonasal sarcoma (BSNS) is a rare low-grade sarcoma with neural and myogenic features. It has been recognized in only a few case reports, all showing similar morphologic features of a low-grade soft tissue tumor arising from the sinonasal tract in middle aged individuals.

JOURNAL OF NEUROLOGICAL SURGERY REPORTS (2022)

添加到收藏夹

Article Oncology

RREB1-MKL2 fusion in a spindle cell sinonasal sarcoma: biphenotypic sinonasal sarcoma or ectomesenchymal chondromyxoid tumor in an unusual site?

Gunhild Mechtersheimer et al.

Summary: Biphenotypic sinonasal sarcoma (BSNS) is a rare low-grade spindle cell sarcoma characterized by dual myogenic and neural differentiation and recurrent gene fusions. A new RREB1-MKL2 fusion gene insertion was identified in a BSNS lesion, adding to the known genetic events associated with this tumor type.

GENES CHROMOSOMES & CANCER (2021)

添加到收藏夹

Article Pathology

Inflammatory leiomyosarcoma shows frequent co-expression of smooth and skeletal muscle markers supporting a primitive myogenic phenotype: a report of 9 cases with a proposal for reclassification as low-grade inflammatory myogenic tumor

Michael Michal et al.

VIRCHOWS ARCHIV (2020)

添加到收藏夹

Article Pathology

Clinicopathologic and Molecular Features of a Series of 41 Biphenotypic Sinonasal Sarcomas Expanding Their Molecular Spectrum

Francois Le Loarer et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2019)

添加到收藏夹

Article Oncology

RREB1-MKL2 fusion in biphenotypic oropharyngeal sarcoma: New entity or part of the spectrum of biphenotypic sinonasal sarcomas?

Aurore Siegfried et al.

GENES CHROMOSOMES & CANCER (2018)

添加到收藏夹

Review Medical Laboratory Technology

Biphenotypic Sinonasal Sarcoma A Review and Update

Cody S. Carter et al.

ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2018)

添加到收藏夹

Article Pathology

PAX7 Expression in Rhabdomyosarcoma, Related Soft Tissue Tumors, and Small Round Blue Cell Neoplasms

Gregory W. Charville et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2016)

添加到收藏夹

Article Cell Biology

Fusion gene profile of biphenotypic sinonasal sarcoma: an analysis of 44 cases

Karen J. Fritchie et al.

HISTOPATHOLOGY (2016)

添加到收藏夹

Article Pathology

Novel PAX3-NCOA1 Fusions in Biphenotypic Sinonasal Sarcoma With Focal Rhabdomyoblastic Differentiation

Shih-Chiang Huang et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2015)

添加到收藏夹

Article Genetics & Heredity

Recurrent PAX3-MAML3 fusion in biphenotypic sinonasal sarcoma

Xiaoke Wang et al.

NATURE GENETICS (2014)

添加到收藏夹

Article Pathology

Low-grade Sinonasal Sarcoma With Neural and Myogenic Features: A Clinicopathologic Analysis of 28 Cases

Jason T. Lewis et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)

添加到收藏夹

Review Cell Biology

The role of Pax genes in the development of tissues and organs:: Pax3 and Pax7 regulate muscle progenitor cell functions

Margaret Buckingham et al.

ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY (2007)

添加到收藏夹

Review Pathology

MyoD1 and myogenin expression in human neoplasia: A review and update

AL Folpe

ADVANCES IN ANATOMIC PATHOLOGY (2002)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.